The QualityStocks Daily Wednesday, May 28th, 2025

Today's Top 3 Investment Newsletters

QualityStocks(SPRO) $2.3500 +244.57%

MarketClub Analysis(SGN) $2.1900 +163.86%

Premium Stock Alerts(SGBX) $1.2400 +124.23%

The QualityStocks Daily Stock List

Spero Therapeutics (SPRO)

Wall Street Resources, QualityStocks, MarketBeat, The Online Investor, MarketClub Analysis, Zacks, FreeRealTime, The Stock Dork, StreetInsider, Schaeffer's, The Street and DrStockPick reported earlier on Spero Therapeutics (SPRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spero Therapeutics, Inc. (NASDAQ: SPRO) (FRA: 2HA) is a clinical-stage biophar-maceutical firm that is engaged in the identification, development and commercializa-tion of treatments for rare illnesses and MDR (multi-drug resistant) bacterial infections.

The firm has its headquarters in Cambridge, Massachusetts and was incorporated in April 2013 by Laurence Rahme and Ankit A. Mahadevia. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the world.

The company is party to a license agreement with Vertex Pharmaceuticals Inc., which involves patents associated with an active metabolite dubbed SPR719 and SPR720. It is also party to a collaboration agreement with the Bill and Melinda Gates Medical Research Institute, involving the development of its SPR720 formulation for treating lung infections brought about by Mycobacterium tuberculosis. In addition to this, the company has license agreements with Everest Medicines for the development, manu-facture and commercialization of SPR206 in South Korea, Greater China and South-east Asian nations; and Meiji Seika Pharma Co. Limited, for developing tebipenemHBr.

The enterprise’s product pipeline comprises of an oral antibiotic dubbed SPR720 for non-TB mycobacterial pulmonary disease; a direct acting agent dubbed SPR206 for the treatment of MDR Gram-negative bacterial infections in hospitals; and a car-bapenem-class antibiotic dubbed tebipenemHBr, for the treatment of urinary tract in-fections.

Spero Therapeutics (SPRO), closed Wednesday's trading session at $2.35, up 244.5748%, on 183,497,549 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.5052/$2.48.

Super League Enterprise, Inc. (SLE)

QualityStocks, The Street, SmarTrend Newsletters, Trading Markets, TheStockAdvisor, StreetAlerts, Coattail Investor, FNNO Newsletters, TradingMarkets, Zacks, Street Insider, Market Wrap Daily, Trade of the Week, Daily Markets, InvestorGuide, Dividend Opportunities, Bull Market Newsletter, Fierce Analyst, BestOtc, Investor Guide, InvestorPlace, Louis Navellier, Small Cap Firm, Barchart, Wealth Daily, Stockhouse, StockWireNews, StreetAuthority Daily, StreetInsider, Wall Street Greek and OTCPicks reported earlier on Super League Enterprise, Inc. (SLE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Super League Enterprise, Inc. (NASDAQ: SLE) is an amateur e-sports content platform which connects a network of brand partners, fans and gamers using its cloud-based technology platform, thus allowing competitive, social and local e-sports to broadcast via a community platform.

Super League Gaming Inc. is based in Santa Monica, California and was founded on October 1, 2014 by Brett Morris, David Steigelfest and John C. Miller. The firm changed its name from Nth Games to Super League Gaming Inc. in June 2015 and serves consumers across the globe.

Super League Gaming provides a gameplay and social forum for the Minecraft community known as Minehut as well as a social video e-sports network known as Framerate, which has user-generated reels.

Apart from engaging in the capturing, generation and distribution of various e-sports content through social media, video-on-demand and live streaming, Super League Gaming also offers team gaming and cloud services, leaderboards, continuous gameplay and recreational gaming events in movie theaters. Some of the firm’s games include Clash Royale, Fortnite and League Legends.

Super League Enterprise, Inc. (SLE), closed Wednesday's trading session at $0.228899, up 18.662%, on 4,963,906 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.145/$1.64.

Pulmatrix Inc. (PULM)

InvestorPlace, BUYINS.NET, TraderPower, MarketClub Analysis, Promotion Stock Secrets, TradersPro, QualityStocks, Wall Street Mover, StockMarketWatch, Jason Bond, Stock News Now, PoliticsAndMyPortfolio.com, MarketBeat, Wealth Insider Alert, The Online Investor, Profit Confidential, TopPennyStockMovers and Stock Hero reported earlier on Pulmatrix Inc. (PULM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pulmatrix Inc. (NASDAQ: PULM) (FRA: 2PU1) is a clinical stage biopharmaceutical firm that is focused on the discovery and development of inhaled therapies that treat and prevent respiratory diseases as well as other ailments.

The firm has its headquarters in Lexington, Massachusetts and was incorporated in 2015, on June 15th by Robert S. Langer Jr., Alexander M. Klibanov, Mark J. Gabrielson and David Alan Ed-wards. The firm serves consumers in the United States.

The company develops products based on its iSPERSE technology (Small Particles Easily Res-pirable and Emitted technology), which allows large or small molecule drugs to be delivered by inhalation for systemic or local applications. The company is party to a license and collaboration agreement with Sensory Cloud Inc., a development and commercialization agreement with Cipla Technologies LLC, which entails developing and commercializing a formulation known as Pul-mazole; and a license agreement with RespiVert Ltd, which affords the company access to a portfolio of kinase inhibitor drug candidates.

The enterprise’s product pipeline comprises of an Isperse dihydroergotamine formulation dubbed PUR3100, which has been developed to treat acute migraines; and a narrow spectrum kinase in-hibitor known as PUR1800, which is undergoing phase 1b clinical trials evaluating its effective-ness in treating chronic obstructive pulmonary disease and lung cancer. The enterprise also devel-ops an inhaled anti-fungal drug dubbed Pulmazole, which is in phase 2b clinical trials and is indi-cated for the treatment and prevention of allergic/hypersensitivity reactions to fungus in individ-uals suffering from serious lung diseases, as well as the treatment of fungal infections.

Pulmatrix Inc. (PULM), closed Wednesday's trading session at $9.09, up 17.4419%, on 76,087 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.72/$10.4.

Fuel Tech (FTEK)

SmarTrend Newsletters, StreetInsider, Wall Street Resources, MarketBeat, TradersPro, Zacks, StreetAuthority Daily, MarketClub Analysis, InvestorPlace, QualityStocks, Marketbeat.com, StockHotTips, FeedBlitz, Investor Ideas, CRWEWallStreet, Investor Update, CRWEPicks, CRWEFinance, BestOtc, DrStockPick, SmallCapVoice, Tiny Gems, StockMarketWatch, Seeking Alpha, ProfitableTrading, PennyToBuck, PennyOmega, Investing Futures, Greenbackers, Alternative Energy, MissionIR, Street Insider, The Street, BUYINS.NET, Uncommon Wisdom and FNNO Newsletters reported earlier on Fuel Tech (FTEK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fuel Tech Inc. (NASDAQ: FTEK) (FRA: FUE1) is a technology firm that is engaged in the pro-vision of air pollution reduction, efficiency improvement, boiler optimization and control solutions to industrial and utility consumers across the globe.

The firm has its headquarters in Warrenville, Illinois and was founded in 1987 by Burr T. Walter. It operates in the industrials sector, under the industrial products industry, in the machinery sub-industry.

The company operates through the other, fuel chem technologies and air pollution control seg-ments. The other segment involves the profit and loss items that aren’t allocated to reportable seg-ments while the fuel chem segment offers programs to enhance the environmental status, boiler heat rate, fuel flexibility, reliability and efficiency of combustion units by controlling acid plume, opacity, corrosion, fouling and slagging as well as the formation of carbon dioxide, sulfur dioxide, particulate matter, ammonium bisulfate and sulfur trioxide, via the addition of chemicals into the furnace utilizing targeted in-furnace injection technology. This latter segment also provides a pro-gram for plants operating in the district heating, university, waste-to-energy, paper and pulp, indus-trial and electric utility markets as well as to owners of furnaces, boilers and other combustion units. On the other hand, the air pollution control technology segment involves technologies to de-crease nitrogen oxides emissions in flue gas from furnaces, incinerators and boilers as well as other stationary combustion sources; over-fire air systems; advanced selective catalytic reduction systems made of SNCR, OFA and ULNB components as well as flue gas conditioning systems.

Fuel Tech (FTEK), closed Wednesday's trading session at $1.73, up 13.0719%, on 297,124 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.8701/$1.8.

Benitec Biopharma (BNTC)

MarketBeat, QualityStocks, MarketClub Analysis, StockMarketWatch, StockEarnings, TraderPower, InsiderTrades, Jason Bond, Profitable Trader Authority, BUYINS.NET, InvestorsUnderground, Money Morning, AllPennyStocks, PennyStockProphet, Trades Of The Day, Promotion Stock Secrets, Schaeffer's, Top Pros' Top Picks and OTCtipReporter reported earlier on Benitec Biopharma (BNTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Benitec Biopharma Inc. (NASDAQ: BNTC) (FRA: BJ93) is a development-stage biotechnology firm that is engaged in developing new genetic therapies.

The firm has its headquarters in Hayward, California and was incorporated in 1995, on April 7th. Prior to its name change, the firm was known as Benitec Biopharma Ltd.

It is currently designing a therapeutic technology platform that has combined gene therapy with RNA (ribonucleic acid), to offer long-lasting and sustained silencing of genes that cause various ailments, from one administration. The technology, which has been dubbed ddRNAi, or DNA (Deoxyribonucleic acid¬)-directed RNA interference is being used to develop drug formulations for life-threatening and chronic human ailment areas, which include infectious ailments and orphan diseases. This technology, which is available from the company under different license options, is safer to use and easier to deliver. This is in addition to being more efficient and targeted. The ddR-NAi is protected by more than forty global patents and possesses the ability to silence genes asso-ciated with thousands of ailments.

The company’s product pipeline is made up of partnered drug and in-house development pro-grams, which are based off of the ddRNAi. Their candidates include an adeno-associated virus termed BB-301, which has been indicated for the treatment of chronic hepatitis B virus infection and oculopharyngeal muscular dystrophy (OPMD).

Benitec Biopharma (BNTC), closed Wednesday's trading session at $16.14, up 12.7095%, on 69,146 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $5.742/$16.9.

Cumberland Pharmaceuticals (CPIX)

QualityStocks, MarketClub Analysis, MarketBeat, Zacks, TradersPro, SmarTrend Newsletters, PennyOmega, CRWEWallStreet, BestOtc, CRWEFinance, CRWEPicks, DrStockPick, Marketbeat.com, PennyToBuck, StockOodles, SmallCapVoice, TraderPower, StockHotTips, StockMarketWatch, StreetInsider, Barchart, BUYINS.NET, Tiny Gems, Momentum Traders, Daily Markets, Premium Stock Alerts, Market FN, Stock Research Newsletter, AnotherWinningTrade and Street Insider reported earlier on Cumberland Pharmaceuticals (CPIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) (FRA: CBJ) is a specialty pharmaceutical firm that is engaged in acquiring, developing and commercializing branded prescription products for rheumatology, gastroenterology and hospital acute care in the U.S. to address poorly met or unmet medical needs.

The firm has its headquarters in Nashville, Tennessee and was founded in 1999. It operates in the healthcare sector, under the biotech and pharma sub-industry. Cumberland Pharmaceuticals sells and markets its products through district managers and sales representatives.

The enterprise’s product pipeline is made up of a formulation that was developed for the treatment of duchenne muscular dystrophy, systemic sclerosis and aspirin-exacerbated respiratory disease dubbed ifetroban, which is currently undergoing a phase 2 clinical trial. The formulation recently concluded phase 2 clinical trials evaluating its effectiveness in treating portal hypertension and hepatorenal syndrome. In addition to this, the enterprise is also involved in the development of the RediTrex injection, indicated for disabling psoriasis and treating severe psoriatic and juvenile idio-pathic arthritis as well as active rheumatoid arthritis; the Vibative injection indicated for the treat-ment of various severe bacterial infections and the Vaprisol injection indicated for the treatment of hypervolemic and euvolemic hyponatremia. Furthermore, it also develops Omeclamox-Pak for treating duodenal ulcer disease and Helicobacter pylori infection; a prescription laxative dubbed Kristalose developed to treat acute and chronic constipation; an injection known as Caldolor for treating fever and pain; and an injection termed Acetadote, which is indicated for treating aceta-minophen poisoning.

Cumberland Pharmaceuticals (CPIX), closed Wednesday's trading session at $5.84, up 9.3633%, on 70,720 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $1.04/$7.25.

Anfield Energy (ANLDF)

QualityStocks, MarketClub Analysis and Streetwise Reports reported earlier on Anfield Energy (ANLDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Anfield Energy Inc. (OTCQB: ANLDF) (FRA: 0ADN) is a mineral exploration firm that is fo-cused on mineral development and exploration activities in the U.S.

The firm has its headquarters in Burnaby, Canada and was founded in 1989. Prior to its name change in December 2017, the firm was known as Anfield Resources Inc. It operates as part of the metal ore mining industry.

The company is working on being a top fuels supplier by developing value through efficient and sustainable growth in its energy metals assets. The enterprise primarily explores for silver, gold, vanadium and uranium deposits and operates via the development, exploration and acquisition of mineral property segment.

The enterprise owns more than 2 surface stockpiles, which are located in the Lisbon Valley and at the Shootaring Canyon and holds interest in the Northstar property. The firm also explores and de-velops uranium mines in Canada and also holds interests in the vanadium/uranium properties locat-ed in Colorado as well as uranium exploration properties in Arizona, Wyoming and Utah. In addi-tion, it also owns various uranium assets, which include the Findlay Tank Breccia Pipes, the Frank M and Velvet-Wood project, as well as the Shootaring Canyon Mill. The Frank M deposit is found north of the Shootaring Canyon Mill while the Velvet-Wood project is found in Utah. The Shootar-ing Canyon Mill is found about 80km south of Hanksville.

Anfield Energy (ANLDF), closed Wednesday's trading session at $0.0827, up 8.8158%, on 5,336,953 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.034/$0.0996.

LightPath Technologies (LPTH)

TaglichBrothers, TradersPro, Wall Street Resources, MarketBeat, LevelStock, StreetInsider, QualityStocks, StockOodles, MarketClub Analysis, Nebula Stocks, PennyRally, StockMarketWatch, Marketbeat.com, AllPennyStocks, PennyOmega, Zacks, PennyStocks24, CRWEPicks, SmallCapVoice, The Bowser Report, BUYINS.NET, Barchart, MegaPennyStocks, Hotstocked, HotOTC, Investing Futures, Hayden IR, FeedBlitz, Early Bird, Daily Trade Alert, Daily Markets, CRWEWallStreet, CRWEFinance, CoolPennyStocks, BullRally, BestOtc, DrStockPick, StockHotTips, Wall Street Grand, Trading Concepts, Trades Of The Day, TopPennyStockMovers, The Street, Street Insider, OTCPicks, Stockpalooza, MadPennyStocks, StockEgg, SmallCapInvestor.com, PennyTrader Publisher, PennyToBuck, PennyStockVille, PennyInvest, Momentum Traders and StockRich reported earlier on LightPath Technologies (LPTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LightPath Technologies Inc. (NASDAQ: LPTH) (FRA: LPZB) is engaged in the design, manu-facture, development and distribution of optical and infrared assemblies and components.

The firm has its headquarters in Orlando, Florida and was incorporated in 1992, on June 15th. It operates in the technology sector, under the technology hardware sub-industry.

The company serves the following major markets: aerospace, defense, telecommunications, in-strumentation, industrial, laser, catalog and distribution. It sells its products directly to consumers in China, Europe and North America as well as through channel partners and distributors internation-ally and in the U.S. Its customers include T-Networks, ThorLabs, Santur, Intel and CyOptics, with the majority of its revenue being generated from the United States.

The enterprise provides diamond-turned and molded infrared aspheric lenses, precision molded glass aspheric optics and other optical components utilized in the production of products that ma-nipulate light, like collimator assemblies, polished ground assemblies and lenses, conventional ground assemblies and lenses. Its products are used in machine vision and sensors, hybrid fiber co-ax Datacom, optical data storage, barcode scanners, automotive safety applications, laser aided in-dustrial tools and medical devices. In addition to this, the enterprise is engaged in the provision of custom optical assemblies which include full engineering design support for mechanics and optics. It also carries out research and development for optical solutions for the traditional optics markets.

LightPath Technologies (LPTH), closed Wednesday's trading session at $2.56, up 7.563%, on 257,771 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $1.04/$4.42.

Onconetix (ONCO)

Premium Stock Alerts, OTCtipReporter, MarketClub Analysis, 360 Wall Street, The Online Investor, Stock Traders Chat, SmarTrend Newsletters, Real Pennies, QualityStocks and PennyTrader reported earlier on Onconetix (ONCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Onconetix Inc. (NASDAQ: ONCO) (FRA: J4T0) is a commercial-stage biotechnology firm fo-cused on researching, developing, and commercializing proprietary therapeutics, diagnostics, and services for clinicians and patients for oncology.

The firm has its headquarters in Cincinnati, Ohio and was incorporated in 2018. Prior to its name change in December 2023, the firm was known as Blue Water Biotech Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

Onconetix’s offerings include Entadfi, a Food and Drug Administration-approved, oral therapeu-tic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate. This for-mulation is a once-daily, oral treatment for BPH that combines finasteride, a 5α-reductase inhibi-tor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. It also offers Proclarix, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. This is a next-generation pro-tein-based blood test that can be done with the same sample as a patient’s regular PSA test. Pro-teomedix is seeking to develop diagnostic, prognostic, and predictive tools to enable cancer man-agement at all stages of disease progression.

The company recently announced that it had signed a non-binding letter of intent contemplating a potential business combination with Ocuvex Therapeutics Inc. This opportunity to combine forces with Ocuvex, which has a pipeline made up of commercial and late clinical-stage ophthal-mic assets, will immediately expand Onconetix’s reach beyond oncology. In turn, this will help enhance their shareholder value and allow both companies to broaden access to capital.

Onconetix (ONCO), closed Wednesday's trading session at $0.073, up 0.8287293%, on 3,551,695 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.0502/$21.4.

Bioadaptives (BDPT)

MarketClub Analysis, QualityStocks, Greenbackers, TheMicrocapNews, Real Pennies and BioMedWire reported earlier on Bioadaptives (BDPT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bioadaptives (BDPT) , through its premium pet wellness division PawPa(TM), announced compelling clinical results for its flagship product Regen(TM) Dog Chews, formulated to naturally stimulate stem cell release and support canine vitality, mobility, and comfort. In veterinarian-led trials, Regen demonstrated a 281.3% increase in circulating stem cells after four weeks. The product’s benefits are further measured using the company’s proprietary APBAR(R) rating system—modeled after the human APGAR score—helping pet owners track improvements in appearance, performance, behavior, attitude, and responsiveness. Crafted with all-natural ingredients including beneficial cyanobacteria and adaptogens, Regen(TM) is veterinarian-recommended, safe, and delivered in a tasty chew dogs love. With no reported adverse effects, Regen(TM) offers a daily, science-backed solution for pet wellness.

To view the full press release, visit https://ibn.fm/gReBb

About BioAdaptives, Inc.

BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness industry. We are dedicated to developing and marketing nutraceutical and wellness products that harness the power of natural ingredients and cutting-edge science. Our mission is to improve the quality of life for our customers by offering products that support optimal health and vitality.

For more information, please visit our website at www.bioadaptives.com .

Bioadaptives (BDPT), closed Wednesday's trading session at $0.07, even for the day, on 6,233 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.005/$0.18.

Silvercorp Metals Inc. (SVM)

TopStockAnalysts, StreetAuthority Daily, Lebed.biz, TradingAuthority Daily, The Street, Top Pros' Top Picks, MarketClub Analysis, TradersPro, InvestorPlace, TheStockAdvisors, Stockhouse, Research Driven Investor, Zacks, MarketBeat, Super Stock Picker, The Wealth Report, Trade of the Week, StreetInsider, Today's Financial News, Top Stock Picks, Greenbackers, BabyBulls, Investor Update, The Growth Stock Wire, Schaeffer's, ChartPoppers, Trading Markets, Dynamic Wealth Report, Energy and Capital, OTCtipReporter, FutureMoneyTrends.com, Hit and Run Candle Sticks, HotStockProfits, Daily Wealth, Daily Trade Alert, Daily Markets, Bourbon and Bayonets, National Inflation Association, SmarTrend Newsletters, Wealth Insider Alert, Wealth Daily, Trades Of The Day, Top Secret Stocks, The Trading Report, The Online Investor, Streetwise Reports, Silver Stock Report, Stansberry Research, Penny Detectives, SmallCapNetwork, Sling-Shot-Stocks, AllPennyStocks, Rick Saddler, QualityStocks, Profitable Trader Authority, PennyStockScholar, Penny Pick Finders and StockOnion reported earlier on Silvercorp Metals Inc. (SVM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ecuador is on the verge of a mine-building surge, as President Daniel Noboa’s reelection coincides with high metals prices and a handful of projects ready for development.

He will start his second term on May 24 on the brink of a mining bonanza, with six projects at the development stage representing at least US$10 billion in investment slated for construction decisions during the 2025-2029 presidential term.

During his current term, truncated to about 18 months as he is completing the term of the previous incumbent, Guillermo Lasso, Noboa has been an advocate of growing Ecuador’s mining sector to boost employment, public coffers and diversify the economy. The country’s needs are many and Noboa recognizes that Ecuador needs the investment and wealth generation that mining can bring.

In a busy 18 months, his administration has overseen projects obtaining permits and signed tax stability agreements with several companies. It has also successfully negotiated a free trade agreement (“FTA”) with Canada, which includes an investment chapter, although without a mining-specific chapter.

Of particular note is that Noboa won in the mining provinces of Azuay, Bolivar, Cotopaxi, El Oro, Esmeraldas, Imbabura, Morona Santiago and Loja.

The positive scenario in Ecuador was quickly recognized by China’s mining giant CMOC (~US$21 billion market cap), which agreed to buy gold-copper developer Lumina Gold for C$581 million at a 71% premium in April for its Cangrejos deposit. China’s Jiangxi Copper also increased its investment into another Ecuador copper-gold developer, Solgold, becoming its largest shareholder with a 12% stake.

International lending agencies such as the World Bank (“WB”) and the International Monetary Fund (“IMF”) are keen for Ecuador to develop its natural resources and presumably be less dependent on loans. “WB and IMF both recently said that Ecuador should drive mining development,” Maria Eulalia Silva, president of Ecuador’s Mining Chamber said recently.

Silva said that Ecuador is no longer naïve when it comes to mining and the people can draw on the positive experience the country has had through the successful developments of Lundin Gold’s Fruta del Norte gold mine and Ecuacorriente’s Mirador copper mine, which both started production in 2019. The development of these two mines have seen Ecuador’s mining exports soar to become its fourth largest export, accelerating from US$275 million in 2018 to US$3.3B in 2023. Higher metal prices and more projects will see these continue to climb.

Silvercorp’s El Domo Project

Leading the charge to develop Ecuador’s next mine is Silvercorp Metals Inc. (TSX: SVM) (NYSE-A: SVM), whose El Domo project, which it will develop with local partner Salazar Resources (TSX.V: SRL), is poised to become Ecuador’s first new mine in nearly a decade. This was one of the projects that received its final permits from the Noboa administration in 2024, with the partners aiming to bring it into production by the end of 2026.

Located 150 km northeast of Guayaquil, the US$241-million development has a 2021 feasibility study that outlined a 10-year operation to produce an annual average of 24Mlb of copper, 26,000oz of gold, 26Mlb of zinc, 488,000oz of silver and 0.9Mlb of lead at an all-in sustaining cost of US$1.26/lb of copper equivalent.

El Domo, which was discovered by Salazar in 2008, hosts proven and probable reserves of 6.5 million tonnes grading 1.93% copper, 2.52g/t of gold, 2.49% zinc, 45.7g/t of silver and 0.25% lead, which makes it among the highest-grade copper-gold projects globally.

El Domo mine construction is fully financed through a US$175.5-million streaming deal that the previous owner, Adventus Mining, secured from Wheaton Precious Metals (TSX: WPM) (NYSE: WPM) (LSE: WPM), along with Silvercorp’s strong balance sheet, which has US$355 million in cash as of December 31, 2024.

Silvercorp, a proven mine builder and operator with a track record of success in China developing and operating low-cost mines, is now applying the same disciplined capital allocation, results-driven approach to the El Domo Project. In April, the company announced the budget for El Domo’s development of US$240.5 million, 3% below the US$247.6 million estimate in the 2021 feasibility, at a time when developers are battling inflation. The cost reduction stems from mine design optimization, lower equipment costs, and a unit-cost contract bidding strategy, resulting in US$32.6 million in direct cost saving. The latest budget also includes a larger contingency of US$31.9 million, up from US$22.0 million, providing additional flexibility.

Silvercorp’s ability to execute efficiently is not theoretical, it has already delivered. At one of its operations in China, the company completed a new tailings storage facility for just US$28 million, coming in well below the original $38 million budget. Silvercorp has also successfully carried out a mill expansion of comparable scale to El Domo on time and under budget. These accomplishments reflect a repeatable, disciplined execution model that Silvercorp is now bringing to Ecuador.

Construction is now underway with pit stripping and plant construction scheduled to commence in Q3 2025, and commissioning targeted in December 2026. Silvercorp has advanced detailed engineering for the tailings storage facility (“TSF”), saprolite waste dump, and water management system, and optimized designs for the open pit mine and process plant, and site access. It has also secured grid power through a powerline contract with the state-owned power company CNEL and is advancing on permitting and sourcing for standby diesel power generators for the dry season, when hydropower will be less available.

With work well underway and momentum building, Silvercorp is positioned to move rapidly through the development process to bring Ecuador’s next mine into production early in President Noboa’s second term at a time when the country needs mining most.

For more information about Silvercorp Metals, please visit silvercorpmetals.com/welcome.

Silvercorp Metals Inc. (SVM), closed Wednesday's trading session at $3.93, off by 0.7575758%, on 4,332,959 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $2.87/$5.32.

SNDL Inc. (SNDL)

StockEarnings, Schaeffer's, QualityStocks, InvestorPlace, StocksEarning, CannabisNewsWire, MarketBeat, Trades Of The Day, BUYINS.NET, Daily Trade Alert, The Street, Kiplinger Today, StreetInsider, FreeRealTime, The Online Investor, Early Bird, TheoTrade, Prism MarketView, CNBC Breaking News, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In the last year, Native American tribes have played an increasingly important role in the legal cannabis industry across the U.S.

As of April, tribal communities operate 77 marijuana stores across nine different states. This marks a 24% increase from 2024, showing that cannabis remains an important avenue for economic development. These shops are run by 59 federally recognized tribes, up 18% from 2024.

On average, tribal cannabis stores are around 4,600 square feet, but they range widely in size, from compact shops under 1,000 square feet to expansive facilities over 10,000 square feet.

Over 80% of the tribes that run cannabis stores also manage casinos, and more than a third of them are situated near a tribal gaming facility.

Tribes operate under their own sovereign laws, which means their cannabis regulations may differ from those of the surrounding state. In some instances, tribal laws are more restrictive; in others, they allow cannabis where the state does not.

For instance, in North Carolina where cannabis remains illegal under state law, the Eastern Band of Cherokee Indians has opened the state’s only legal marijuana store—The Great Smoky Cannabis Co.—offering adult-use cannabis under tribal jurisdiction. Similarly, Washington leads the country in tribal cannabis retail with 25 stores operated by 18 tribes. California has overtaken Nevada as the second-largest hub for tribal cannabis businesses, boasting 15 stores run by 12 tribes.

New York and Minnesota have seen a burst of activity, largely because of delays in state-level licensing. With few or no licensed dispensaries available, consumers in these states have turned to tribally owned stores. These businesses have stepped in to meet demand, offering legal alternatives to the illicit market. In Minnesota, for instance, tribal dispensaries are currently the only legal option for recreational cannabis buyers.

Beyond retail, the tribes are also building out cultivation and manufacturing operations. Some of these are fully integrated businesses like Great Smoky Cannabis Co., while others focus on one part of the supply chain. In Minnesota, the Mille Lacs Band of Ojibwe is concentrating on developing a large-scale cultivation facility, while White Earth Nation has sold surplus product to other tribal stores and signed a deal to open up to eight more outlets.

Some tribes have taken another approach by licensing individual tribal members to operate marijuana businesses. New York’s Saint Regis Mohawk Tribe has approved over 20 marijuana retailers.

With more tribes entering the market, expanding operations, and forming strategic partnerships, tribal involvement in cannabis is expected to grow significantly in the coming year.

The reform movement and cannabis firms like SNDL Inc. (NASDAQ: SNDL) are likely to applaud the contribution of native tribes in helping to provide legal marijuana products in different communities and thereby preventing the population from depending on products supplied by black market actors.

SNDL Inc. (SNDL), closed Wednesday's trading session at $1.3, up 0.7751938%, on 667,010 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $1.24/$2.4.

The QualityStocks Company Corner

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital.

Combined with a prior strategic investment, for which a financing term sheet has also been signed, the total financing investment, assuming both are closed, represents an expected $10.3 million for HOPE acquisition funding, supporting initial acquisitions of Dura Medical, Kadima, and NeuroSpa clinics.

The expanding HOPE clinic network will deliver neuroplastic therapies for depression and PTSD, including ketamine and TMS.

NRx continues regulatory progress for NRX-100 (IV ketamine) and NRX-101 (oral bipolar depression therapy).

The FDA waived NRx's $4.3 million drug application fee, and patents could protect NRX-100 through 2045.

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a nationwide mental health clinic network while progressing toward FDA approval of its NMDA-based therapies for suicidal depression and bipolar disorder.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Wednesday's trading session at $2.59, up 0.3875969%, on 1,230 volume. The average volume for the last 3 months is 306,460 and the stock's 52-week low/high is $1.1/$6.01.

Recent News

Newton Golf Company Inc. (NASDAQ: NWTG)

The QualityStocks Daily Newsletter would like to spotlight Newton Golf Company Inc. (NASDAQ: NWTG).

Newton Golf reports three-figure revenue growth in first quarter of 2025.

Newton Motion shaft adoption has surpassed 30 professionals.

Company's revenue guidance for 2025 is forecast to range between $6.5 and $7 million.

With the launch of its newest shaft family, Newton Golf Company (NASDAQ: NWTG) is seeing triple-figure year-over-year revenue growth, according to the company's latest financial numbers ( https://ibn.fm/hAQWB ). The company released its financial report for Q1 2025, noting that revenue had increased an impressive 246% during the first three months of the year.

Newton Golf Company (NASDAQ: NWTG) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after reporting $6.2 million in stockholders' equity in its Q1 2025 10-Q filing. The Nasdaq confirmation closes a compliance matter originally raised in April. Executive Chairman Greg Campbell credited the resolution to the company's financial strength and growing market traction. Newton Golf posted 246% year-over-year revenue growth in Q1 2025, with gross margins reaching 70%, driven by rising adoption of its Newton Motion shaft across retail channels and pro tours. Now used by over 40 professional players, the brand continues to expand globally and reinforce its innovation credentials within the performance golf segment.

To view the full press release, visit https://ibn.fm/YAiNH

Newton Golf Company Inc. (NASDAQ: NWTG), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.

As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, Newton Golf Company is exploring expansion into golf apparel and other product categories.

The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.

Newton Golf Company is headquartered in Camarillo, California.

Products

Newton Golf Company is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:

  • Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
  • Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
  • Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.

All Newton Golf Company products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.

Market Opportunity

The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.

Key industry trends supporting growth include:

  • The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
  • A shift toward customization, as golfers seek tailored products that enhance performance.
  • A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.

Newton Golf Company’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.

Leadership Team

Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.

Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.

Investment Considerations
  • Newton Golf Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
  • The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
  • U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
  • An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
  • Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.

Newton Golf Company Inc. (NASDAQ: NWTG), closed Wednesday's trading session at $1.73, up 2.9762%, on 512 volume. The average volume for the last 3 months is 306,014 and the stock's 52-week low/high is $1.35/$195.

Recent News

Vivakor Inc. (NASDAQ: VIVK)

The QualityStocks Daily Newsletter would like to spotlight Vivakor Inc. (NASDAQ: VIVK).

Investing in clean technologies not only benefits the environment but also enhances operational efficiency and cost effectiveness.

In its 2024 full-year and fourth-quarter financial results, Vivakor reported remarkable growth, with Q4 revenue increasing 201% YOY.

Other key milestones for the company included the completion of additional gathering lines and the acquisition of Endeavor Entities.

In an era where environmental sustainability has become a global priority, few industries face more scrutiny than oil and gas. As governments, consumers and investors demand cleaner practices and corporate accountability, companies are being urged to innovate and adapt—or risk falling behind. Vivakor (NASDAQ: VIVK) , a vertically integrated energy infrastructure and environmental services company, has taken up this challenge with remarkable success. Focused on transportation, storage, reuse and remediation of oilfield fluids and waste, Vivakor is proving that environmental responsibility and profitability are not mutually exclusive.

Vivakor Inc. (NASDAQ: VIVK) is a vertically integrated energy infrastructure and environmental services company, focused on the transportation, storage, reuse, and remediation of oilfield fluids and waste. The company operates a large-scale oilfield trucking fleet serving key U.S. energy regions, enabling end-to-end solutions for the handling of crude oil and produced water. Through long-term contracts and strategic asset positioning, Vivakor delivers critical services to upstream energy operators seeking efficient and environmentally responsible operations.

Vivakor’s vision is to become a leader in sustainable energy logistics and remediation by combining innovative infrastructure with environmentally conscious practices. The company’s integrated model allows it to optimize the flow and treatment of petroleum-based materials across the value chain. By owning and operating both the logistics and remediation components, Vivakor is well-positioned to support an evolving energy ecosystem.

The company’s mission is to develop, acquire, accumulate, and operate assets, properties, and technologies that enhance efficiency and sustainability within the energy sector. This includes the ongoing development of oilfield waste remediation facilities, which will facilitate the recovery and reuse of petroleum byproducts.

The company is headquartered in Dallas, Texas.

Operations

Vivakor’s operations span crude oil and produced water gathering, transportation, storage, and remediation. Leveraging a large-scale oilfield trucking fleet, the company delivers mission-critical logistics services under long-term agreements with energy producers. Its integrated facility assets support efficient fluid movement and storage while aligning with evolving environmental standards.

The company is actively developing oilfield waste remediation capabilities designed to recycle and safely dispose of petroleum byproducts. These facilities will process contaminated materials and convert them into reusable resources, supporting more sustainable field operations. In 2023, Vivakor expanded its infrastructure through the acquisitions of Silver Fuels Delhi and White Claw Colorado, strengthening its midstream footprint and operational reach across key U.S. basins.

Vivakor delivered triple-digit revenue growth in 2023, reflecting increased demand for its integrated services and the impact of strategic asset expansion. This momentum positions the company for further scale as environmental regulations and logistics needs continue to evolve across the energy sector.

Market Opportunity

Vivakor operates at the intersection of energy logistics and environmental remediation—two sectors undergoing transformation amid rising regulatory pressure and sustainability goals. According to Allied Market Research, the global oilfield services market was valued at $268.1 billion in 2022 and is projected to reach $346.45 billion by 2032, growing at a CAGR of 2.6% during the forecast period. As producers seek efficiency and environmental compliance, demand for integrated logistics and remediation services is expected to grow.

Additionally, the global produced water treatment market is forecast to reach $12.2 billion by 2028, up from $8.6 billion in 2023, driven by increased recycling efforts and stricter disposal regulations. Vivakor’s remediation facilities, once operational, will directly serve this need by offering oilfield clients sustainable waste processing and reuse options.

By addressing both logistical and environmental challenges in energy production, Vivakor is strategically positioned to capture value across multiple growth verticals in a dynamic market landscape.

Leadership Team

James Ballengee, President & Chief Executive Officer, is an energy entrepreneur and operator with over 15 years of experience in oilfield logistics, midstream infrastructure, and energy asset development. Prior to leading Vivakor, he served as Managing Partner at Silver Fuels Delhi and White Claw Colorado, both of which were acquired by Vivakor in 2023. He has held executive roles in multiple energy companies where he focused on developing vertically integrated logistics and remediation systems. Ballengee specializes in contract structuring, capital deployment, and building operationally efficient service platforms across the energy sector.

Tyler Nelson, Chief Financial Officer, is a licensed CPA with extensive experience in public company financial leadership, SEC reporting, and audit readiness. Prior to joining Vivakor, he served as Corporate Controller at two Nasdaq-listed companies and held audit roles at prominent regional accounting firms. His background spans oil & gas, renewables, and technology, where he has led successful finance transformations, SOX compliance rollouts, and investor reporting improvements. At Vivakor, Nelson oversees all financial operations, capital strategy, and compliance functions.

Investment Considerations
  • Vivakor achieved substantial revenue growth in 2023, driven by expanded logistics operations and newly integrated midstream assets.
  • The company operates a large-scale oilfield trucking fleet under long-term contracts, providing recurring revenue and service continuity.
  • Its remediation facilities, once operational, will address a produced water treatment market forecast to reach $12.2 billion by 2028.
  • Recent acquisitions have enhanced Vivakor’s infrastructure footprint and extended its service reach across key U.S. energy basins.
  • The company’s integrated model aligns with industry trends favoring sustainability, compliance, and full-cycle fluid management.

Vivakor Inc. (NASDAQ: VIVK), closed Wednesday's trading session at $0.7319, up 3.5219%, on 7,819 volume. The average volume for the last 3 months is 34,121 and the stock's 52-week low/high is $0.5504/$3.45.

Recent News

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF)

The QualityStocks Daily Newsletter would like to spotlight Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF).

Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) has appointed IBN to manage its corporate communications as the company advances its gold and silver projects in Nevada's Walker Lane district. With four U.S.-based properties and a focus on unlocking oxide resource value from past-producing sites, Lahontan aims to transition toward near-term production through capital-efficient strategies. IBN will support this vision by deploying its expansive distribution network—spanning more than 5,000 outlets and 70+ brands—to boost visibility and engagement with investors, media, and the broader market.

To view the full press release, visit https://ibn.fm/JIfWm

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one controlled via a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-rich projects.

The company’s mission is to responsibly develop and expand its oxide resources while minimizing capital intensity and maximizing economic returns. Leveraging a strong technical team with a track record of advancing projects and building mines, Lahontan is focused on growing gold and silver resources and hitting permitting milestones across multiple sites. Its strategy prioritizes scalability, efficiency, and timely value realization for shareholders.

By maintaining full project ownership and a capital-light development model, Lahontan Gold is positioned to rapidly transition from development to production.

The company is headquartered in Toronto, Ontario.

Projects

Santa Fe Mine

The 26.4 km² Santa Fe Mine is Lahontan’s flagship asset and core development priority. A past-producing open-pit, heap-leach gold and silver operation, Santa Fe historically yielded more than 359,000 ounces of gold and 702,000 ounces of silver between 1988 and 1995. The site benefits from established infrastructure—including power, water, and road access—and more than 79% of its known resources are unencumbered by royalties.

A 2024 NI 43-101 resource estimate outlines 1.54 million ounces of gold equivalent (AuEq) in the Indicated category and 0.41 million ounces Inferred, all pit-constrained. Oxide resources average among the highest grades in the state and are distributed across five known deposits. A 2025 Preliminary Economic Assessment (PEA) projects strong economic returns, including an after-tax NPV5% of $200 million, a 34.2% internal rate of return (IRR), and average annual production of approximately 50,000 ounces AuEq over an eight-year mine life.

Permitting is well underway for both the Exploration and Mine Plans of Operation, covering over 12 km² and more than 700 drill holes. The company is targeting construction permits in late 2026 and continues to pursue oxide resource expansion and metallurgical optimization, particularly within the Slab-Calvada corridor.

West Santa Fe

West Santa Fe lies just 13 kilometers from the flagship and is being explored as a potential satellite operation. The project is defined by a shallow, oxide-dominant gold-silver system with a conceptual target of 0.5 to 1.0 million ounces AuEq based on historic drilling and recent surface sampling, which returned up to 2.61 g/t Au and 899 g/t Ag (14.6 g/t AuEq). A 6,300-meter Phase One reverse circulation drill program is scheduled for 2025 to validate historical data and support a maiden resource estimate. Development is streamlined under a low-cost option agreement and a rapid permitting path via Notice of Intent.

Moho and Redlich

The Moho and Redlich projects provide additional longer-term upside within Lahontan’s portfolio. Moho features high-grade, oxidized epithermal veins with historic production at grades of 20–25 g/t Au and 300 g/t Ag. A 2019 core drill program confirmed the presence of high-grade mineralization at depth. Redlich, located along trend from the historic Candelaria silver mine, hosts disseminated Ag mineralization in epithermal veins and hydrothermal breccias but remains untested by drilling. While no near-term programs are currently disclosed, both assets represent future exploration optionality.

Market Opportunity

Lahontan Gold operates in Nevada, consistently ranked the top global mining jurisdiction by the Fraser Institute due to its transparent permitting process, legal stability, and established infrastructure. Nevada produces over 4.5 million ounces of gold annually, generating approximately $9 billion in value, and ranks fifth globally in total gold production.

According to the World Gold Council, total gold demand in Q1 2025 reached 1,206 tonnes, up 1% year-over-year, marking the strongest first quarter since 2016. Central banks added 244 tonnes to reserves, a slight slowdown from the prior quarter but well within the strong buying range observed over the past three years. Meanwhile, silver demand is supported by strong industrial usage in solar panels, electric vehicles, and semiconductors, with long-term deficits forecast in the physical silver market.

With macro-driven demand for gold, technology-driven silver consumption, and strong institutional buying across both metals, Lahontan is uniquely positioned to capitalize through its portfolio of oxide-focused projects in a top-tier jurisdiction—offering near-term production potential and longer-term resource expansion.

Leadership Team

Kimberly Ann, Founder, CEO, President & Executive Chair, is a veteran mining executive with a track record of founding and scaling junior resource companies. She has raised over $210M in financing and led the $340M buyout of Prodigy Gold. Her prior roles include CFO of PPX Mining and founder of Latin America Resource Group, which merged with Carube Copper to form C3 Metals.

Brian Maher, Founder and VP of Exploration, is an economic geologist with more than 45 years of experience. He previously led Prodigy Gold as CEO, where he helped develop the Magino gold project before its $341M acquisition. His career includes senior roles at ASARCO, Hochschild Mining, and PPX Mining, where he oversaw exploration and production in the Americas.

John McNeice, Chief Financial Officer, is a Chartered Professional Accountant with three decades of experience in public company reporting. He has served as CFO for seven public resource companies and played a key role in Ur-Energy Inc.’s TSX IPO and $150M in financings. He also serves as CFO for Gold79 Mines, C3 Metals, and Northern Graphite Corp.

Current Initiatives
  • Commencing Summer gold and silver resource expansion drilling at Santa Fe
  • Optimizing Preliminary Economic Assessment reflecting +$3,000 gold price
  • Exploration Plan of Operations heading into NEPA stage with approval expected Q4 2025
  • Targeting late 2026 mining permit and breaking ground at Santa Fe in 2027
Investment Considerations
  • The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories.
  • A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing.
  • All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction.
  • Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study.
  • The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations.

Lahontan Gold Corp. (OTCQB: LGCXF), closed Wednesday's trading session at $0.05665, up 5.3953%, on 457,001 volume. The average volume for the last 3 months is 771,970 and the stock's 52-week low/high is $0.0143/$0.1005.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Klarna's CEO and co-founder, Sebastian Siemiatkowski, has acknowledged that the company's heavy reliance on AI for customer support hasn't gone as planned. Speaking at the company's headquarters in Stockholm, he admitted that cutting costs had been too much of a priority, leading to a drop in service quality. Klarna had paused hiring for more than a year while pushing forward with AI integration. Now, Siemiatkowski says it's time to refocus. Siemiatkowski revealed that the company is returning to hiring customer service staff and testing a more flexible support model. Despite resuming recruitment, Klarna's total workforce is still expected to decline over time through natural attrition. Siemiatkowski estimated that the number of employees could drop from 3,000 to about 2,500 within a year. Comparing himself jokingly to Elon Musk, he said he tends to be overly optimistic about timelines but believes these changes are coming soon, likely within the next year. For AI firms like D-Wave Quantum Inc. (NYSE: QBTS), Klarna's willingness to keep integrating AI solutions into operations despite minor hiccups shows that the market is ready to embrace cutting-edge technologies that have the potential to improve service delivery while cutting costs.

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $17.55, even for the day, on 945,491 volume. The average volume for the last 3 months is 92,648,948 and the stock's 52-week low/high is $0.7505/$19.765.

Recent News

SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

The United States Senate has blocked a landmark California electric vehicle mandate that would have required the state to phase out gas-powered vehicles in favor of battery electric vehicles (BEVs). Although California already has the largest fleet of BEVs in the U.S., the mandate aimed to accelerate electrification by pressuring carmakers to develop more EV models. The current administration has spent the past several months rolling back many of the previous administration's climate-related policies. President Donald Trump has been outspoken in his opposition to using federal funds for climate action and has pledged to reverse Biden-era green energy policies, including plans to rescind unspent federal allocations for clean energy initiatives. Now Chinese carmakers are emerging as a serious threat in the global market, particularly in the EV segment, and are becoming strong competitors to industry leaders like Tesla. If the U.S. fails to prioritize electrification, China could cement its position as the world's top EV producer, dominating a key industry expected to play a pivotal role in the global economy for decades to come. Green energy ecosystem players like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) may now have to rethink their market strategies and projections in light of the way the U.S. federal administration is becoming increasingly hostile to the transition to zero-emission vehicles. The growth of the market for batteries could significantly slow down.

SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

SolarBank has offices in Toronto, Ontario and New York.

Projects

SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

SolarBank Corp. (NASDAQ: SUUN), closed Wednesday's trading session at $1.59, even for the day, on 22 volume. The average volume for the last 3 months is 148,395 and the stock's 52-week low/high is $1.55/$6.65.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

On May 22, the U.S. House of Representatives approved the reconciliation bill for the 2025 budget with a one-vote difference between those in support of the bill and those opposed to it. The American Hospital Association says this legislation is going to have notable impacts upon healthcare insurance and Medicaid. Rick Pollack, the CEO and President of AHA, wrote to Congress on the eve of the House vote. In that statement, he expressed the association's concerns about several provisions focused on the health insurance marketplace and Medicaid. He pointed out that the reductions to Medicaid funding are likely to have an adverse effect on not only Medicaid beneficiaries but also all patients in every community. AHA also says those changes are abrupt and will throw the budgets of state governments into disarray, thereby compromising the ability of states to provide essential services to residents. Given that the law would take effect as soon as the President enacts it, there won't be ample time for countermeasures to address the budgetary shocks that states will experience. The association therefore urged lawmakers in the House to oppose those provisions geared at dismantling the critical programs under Medicaid. Now that the House has approved the bill, it heads to the U.S. Senate. Some changes are likely to be made prior to calling a vote on the document. It remains to be seen how the operations of smaller health insurance firms like Astiva Health will be impacted by the changes to the federal government-run Medicaid system.

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

ESGold (CSE: ESAU) (OTCQB: ESAUF) , a fully permitted pre-production resource company focused on clean mining innovation, was featured in a recent Investorideas.com snapshot highlighting Canadian gold companies advancing amid rising gold prices. ESGold reported the successful delivery of its Humphrey spiral concentrators to the Montauban site in Quebec, completing the gravity separation circuit required for gold and silver recovery from historic tailings. The circuit, designed for up to 1,000 TPD throughput, is a cornerstone of the company's low-impact tailings-to-cash flow model. CEO Paul Mastantuono emphasized the significance of this milestone, noting construction is progressing on schedule with first production still targeted for year-end 2025. ESGold is also preparing an updated PEA and plans to release a 3D geological model in the coming weeks. The company's progress was presented alongside strong Q1 2025 results from Canadian peers including Barrick Gold, Kinross Gold, and B2Gold, as Canada solidifies its position as the fourth-largest gold-producing nation globally.

To view the full press release, visit https://ibn.fm/O4iRN

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Wednesday's trading session at $0.3167, off by 1.0312%, on 22,100 volume. The average volume for the last 3 months is 84,100 and the stock's 52-week low/high is $0.0221/$0.5.

Recent News

ONAR Holding Corp. (OTCQB: ONAR)

The QualityStocks Daily Newsletter would like to spotlight ONAR Holding Corp. (OTCQB: ONAR).

ONAR (OTCQB: ONAR) , a marketing technology firm and agency network, will present at the Centurion One Capital 5th Annual LA Summit, set for June 5–6 at The Beverly Hills Hotel. Chairman and CEO Claude Zdanow is scheduled to speak at 1:50 p.m. PDT on June 6 and will also host one-on-one investor meetings. The event brings together top public and private companies with leading investors from North America and abroad. ONAR's participation comes shortly after appointing Jon Bond to its board, adding momentum to the company's evolving growth narrative.

To view the full article, visit https://ibn.fm/WLJkn

ONAR Holding Corp. (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide.

Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. With employees across five continents, the company is aggressively expanding its team to support both organic growth and an active acquisition pipeline. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings across industries.

ONAR’s mission is to drive measurable client success through integrated, high-impact marketing solutions that blend creativity, data science, and technology. As it continues to expand, ONAR is focused on building a global marketing services network that serves companies ranging from $10 million to $300 million in revenue.

The company is headquartered in Miami, Florida.

Portfolio

ONAR’s operations are organized across a network of specialized agencies that together serve more than 45 clients across a wide range of industries. Each agency brings deep domain expertise and a results-driven approach:

  • Storia: A premier performance marketing agency specializing in brand growth, paid media, and SEO. With a focus on data-driven excellence, Storia delivers highly targeted marketing strategies that maximize ROI across digital platforms. The agency partners with leading brands to drive measurable revenue outcomes and long-term brand equity.
  • Of Kos: A full-service healthcare marketing agency committed to redefining the patient experience. Of Kos partners with healthcare professionals to deliver integrated campaigns that not only increase patient engagement but also elevate the standard of care across the healthcare landscape. Its work bridges marketing innovation and healthcare expertise to create real impact.
  • CHALK: An experiential marketing agency that transforms bold ideas into unforgettable, immersive experiences. CHALK’s team of event architects specializes in designing events that break boundaries — from brand activations and pop-ups to major corporate experiences — creating lasting emotional connections between brands and audiences.
  • ONAR Labs: The company’s pioneering technology incubator, ONAR Labs, brings together data scientists, engineers, and industry experts to develop proprietary marketing technologies. Every product is rigorously battle-tested within the agency network before commercialization, ensuring that ONAR Labs delivers real-world solutions that enhance marketing performance and client success.

Market Opportunity

ONAR operates at the intersection of marketing services and marketing technology, two sectors undergoing rapid evolution and expansion. The global digital marketing software market alone is projected to reach $264.15 billion by 2030, expanding at a CAGR of 19.4%, according to Grand View Research. Meanwhile, healthcare marketing and experiential marketing are experiencing renewed momentum, as companies seek to create more personalized and immersive customer experiences.

With its integrated, AI-driven platform and expertise across multiple high-growth verticals, ONAR is well positioned to capture a growing share of the marketing spend from mid-sized to large enterprise clients. As businesses increasingly prioritize digital transformation, customer experience, and data-driven marketing, ONAR’s diversified offerings and proprietary technologies through ONAR Labs create meaningful competitive advantages in a highly fragmented market.

Leadership Team

Claude Zdanow, Chief Executive Officer, is a seasoned entrepreneur and business leader with deep experience scaling service organizations and technology platforms. Prior to founding ONAR, he built and successfully exited multiple companies in marketing and media, combining creative vision with operational discipline to drive measurable client growth.

Chris Becker, President, brings extensive operational and strategic expertise to ONAR, focusing on driving agency performance and expanding the company’s integrated service offering. His leadership emphasizes operational rigor, client success, and scaling the company’s footprint across industries and regions.

Patricia Kaelin, Chief Financial Officer, oversees ONAR’s financial operations and strategic planning. A distinguished financial executive with more than 25 years of experience in scaling high-growth companies and leading finance teams at both public and private companies, she expertly manages financial strategy, M&A transactions, and provides a strong foundation for ONAR’s continued expansion and acquisition initiatives.

Sam Mendez, Chief of Staff, fosters seamless collaboration across the organization. She expertly manages strategic projects, facilitates clear communication channels, and acts as a key point of contact to maximize the executive team’s impact and advance organizational goals.

Investment Considerations
  • ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals.
  • The company is actively pursuing an acquisition-driven expansion strategy to grow its marketing agency network.
  • ONAR Labs provides a proprietary technology pipeline, offering additional revenue streams beyond traditional marketing services.
  • A strong leadership team with proven track records in business growth, financial management, and technology commercialization positions the company for long-term success.
  • ONAR’s focus on middle market and growth-stage clients aligns with sectors expected to see a sustained rise in marketing spend over the next decade.

ONAR Holding Corp. (OTCQB: ONAR), closed Wednesday's trading session at $0.05, off by 3.2882%, on 100 volume. The average volume for the last 3 months is 14,270 and the stock's 52-week low/high is $0.03/$0.167.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

 

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Wednesday's trading session at $1.1, up 14.71%, on 132,246 volume. The average volume for the last 3 months is 161,130 and the stock's 52-week low/high is $0.33/$1.64.

Recent News

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Investment Considerations
  • Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
  • AVERSA technology can be incorporated into any transdermal patch.
  • The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
  • Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
  • In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.

Nutriband Inc. (NASDAQ: NTRB), closed Wednesday's trading session at $6.31, up 5.5184%, on 8 volume. The average volume for the last 3 months is 52,153 and the stock's 52-week low/high is $3.7223/$11.78.

Recent News

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Wednesday's trading session at $2.2513, up 2.7991%, on 2,071 volume. The average volume for the last 3 months is 6,365 and the stock's 52-week low/high is $2.11/$4.6599.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.